Abstract
Thrombocytopenia in liver diseases has been considered secondary to portal hypertension or to a consumption mechanism associated with fibrinolytic disorders. Several conflicting clinical reports and evidence from experimental models justify the above mentioned mechanisms only in part. We propose that thrombocytopenia may be consequent to an inadequate synthesis of a factor stimulating trombopoiesis produced by the liver.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have